Development of health-based exposure limits for radiofrequency radiation from wireless devices using a benchmark dose approach

Table 4 BMDS modeling of cancer incidence in male rats using the MS Combo model. Neoplasm incidence data modeled here did not include the highest exposure dose of 6 W/kg

Exposure condition and tumor type	BMD₅	BMDL₅	BMD₁₀	BMDL₁₀
CDMA, heart schwannoma	4.09^a	2.12	8.41^a	3.50
CDMA, pituitary gland adenoma	0.60	0.37	1.23	0.77
CDMA, liver adenoma	3.37^a	1.84	6.93^a	3.78
CDMA, combined heart schwannoma, liver adenoma, and pituitary gland adenoma	0.45	0.31	0.93	0.63
GSM, heart schwannoma	6.87^a	3.01	Could not be modeled
GSM, brain malignant glioma	3.40^a	1.86	6.99^a	3.46
GSM, brain meninges neoplasm (benign and malignant)	4.21^a	1.90	Could not be modeled
GSM, adrenal medulla pheochromocytoma (benign and malignant)	0.58	0.38	1.20	0.78
GSM, pituitary gland adenoma	1.06	0.51	2.17	1.06
GSM, combined heart schwannoma, brain glioma, and meninges neoplasm, adrenal pheochromocytoma, and pituitary gland adenoma	0.30	0.21	Could not be modeled

^a Calculated BMD value is greater than the 3 W/kg highest exposure dose included in this analysis

ISSN: 1476-069X